ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 632573 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 632573; 2) Community: the network communities that were significantly associated with the response to NSC 632573; 3) Molecule: the relationships between components within communities and NSC 632573; 4) MDR: the compounds that were significantly associated with the NSC 632573.

NSC Compound Enrichment Correlation
NSC 715572 Null 0.0438391811600418 0.32060968
NSC 105132 Deoxycamptothecin 0.0478540623811426 0.58877365
NSC 13275 Null 0.0478540623811426 0.30113824
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0478540623811426 0.30082199
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0478540623811426 0.1674862
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0478540623811426 0.43236032
NSC 13484 Null 0.0478540623811426 0.37729983
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.0478540623811426 0.54018467
NSC 256926 HYRCANOSIDE 0.0478540623811426 0.45225471
NSC 287069 Epicorazine A 0.0478540623811426 0.38518001
Total:121  Current:113    [First] [Prev] [Next] [Last]